From all 29 different mutations detectable by both NGS panels (plasma and tumor), seven different variants (24.13%; EGFR L858R in two patients, KRAS G13D and Q61H and TP53 G244D, V197M, R213P, and R273H) were detected only in plasma and not in the tumor itself. The gene discussed is KRAS; the disease is neoplasm.